We are live on
!
Find out more
AF
Amalgamated Financial Portfolio holdings
AUM
$12.6B
This Fund
S&P 500
This Quarter
Est. Return
-2.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.6B
AUM Growth
–
Cap. Flow
+$12.4B
Cap. Flow
% of AUM
98.67%
Top 10 Holdings %
Top 10 Hldgs %
24.33%
Holding
3,002
New
2,999
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$709M |
| 2 |
Microsoft
MSFT
|
+$617M |
| 3 |
Amazon
AMZN
|
+$371M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$223M |
| 5 |
Tesla
TSLA
|
+$208M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.52% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 13.05% |
| 4 | Consumer Discretionary | 12.17% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
First Bank
FRBA
$454M
| $27K | ﹤0.01% |
+1,884
| New | +$27.1K |
|
2652
FS Bancorp
FSBW
$320M
| $27K | ﹤0.01% |
+863
| New | +$28.1K |
|
2653
Pliant Therapeutics
PLRX
$65M
| $27K | ﹤0.01% |
+3,844
| New | +$39.2K |
|
2654
Superior Group of Companies
SGC
$225M
| $27K | ﹤0.01% |
+1,537
| New | +$30.5K |
|
2655
Teekay
TK
$985M
| $27K | ﹤0.01% |
+8,398
| New | +$27.2K |
|
|
JNCE
2656
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $27K | ﹤0.01% |
+3,986
| New | +$28.4K |
|
2657
Citizens
CIA
$192M
| $26K | ﹤0.01% |
+6,036
| New | +$27.3K |
|
2658
CorMedix
CRMD
$584M
| $26K | ﹤0.01% |
+4,747
| New | +$21.7K |
|
2659
FTC Solar
FTCI
$44.9M
| $26K | ﹤0.01% |
+535
| New | +$26.7K |
|
2660
Immunic
IMUX
$195M
| $26K | ﹤0.01% |
+226
| New | +$26.2K |
|
2661
Kinetik
KNTK
$3.62B
| $26K | ﹤0.01% |
+812
| New | +$26.5K |
|
2662
Matrix Service
MTRX
$335M
| $26K | ﹤0.01% |
+3,151
| New | +$23.8K |
|
|
TEAD
2663
Teads Holding Co
TEAD
$66.9M
| $26K | ﹤0.01% |
+2,462
| New | +$30.9K |
|
2664
Outlook Therapeutics
OTLK
$191M
| $26K | ﹤0.01% |
+725
| New | +$22.6K |
|
2665
Ribbon Communications
RBBN
$383M
| $26K | ﹤0.01% |
+8,506
| New | +$34.9K |
|
2666
RxSight
RXST
$260M
| $26K | ﹤0.01% |
+2,072
| New | +$24.9K |
|
2667
Tilly's
TLYS
$128M
| $26K | ﹤0.01% |
+2,741
| New | +$33.8K |
|
2668
UroGen Pharma
URGN
$2.29B
| $26K | ﹤0.01% |
+2,960
| New | +$23.1K |
|
|
CBAY
2669
DELISTED
Cymabay Therapeutics
CBAY
| $26K | ﹤0.01% |
+8,381
| New | +$26.4K |
|
|
EAR
2670
DELISTED
Eargo, Inc. Common Stock
EAR
| $26K | ﹤0.01% |
+246
| New | +$24.3K |
|
2671
American Superconductor
AMSC
$1.59B
| $25K | ﹤0.01% |
+3,339
| New | +$28.6K |
|
2672
Byrna Technologies
BYRN
$101M
| $25K | ﹤0.01% |
+3,012
| New | +$30.7K |
|
2673
Citius Pharmaceuticals
CTXR
$18.7M
| $25K | ﹤0.01% |
+549
| New | +$21.7K |
|
2674
Cue Biopharma
CUE
$114M
| $25K | ﹤0.01% |
+168
| New | +$35.6K |
|
|
DRRX
2675
DELISTED
DURECT Corp
DRRX
| $25K | ﹤0.01% |
+3,695
| New | +$25.7K |
|
Similar funds
MCM
NIPH
PSUF
IA
SCC
BAM
ACI
ACM
Amalgamated Financial's Q1 2022 Portfolio in Review
Q1 2022 is the first quarter with a 13F filing on record for Amalgamated Financial, which disclosed 3,002 positions worth $12.6B. Its ten largest holdings account for 24% of the portfolio.
Its largest position is Apple: 4,217,665 shares worth $736M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Financials and Healthcare.
- Amalgamated Financial's largest Q1 2022 buy was Apple: 4,217,665 shares worth $736M.
- Amalgamated Financial's ten largest holdings make up 24% of its $12.6B portfolio in Q1 2022.
- Amalgamated Financial disclosed 3,002 positions in Q1 2022, its first 13F filing on record.
Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.